The Medicare and Medicaid drug-coverage policies that some now view as contributing to drug price increases have been in place for many years, but it took the hepatitis C drug Sovaldi to spark the explosion in prices, attendees and presenters at a Federal Trade Commission workshop on the prescription drug market said Wednesday (Nov. 8). Drug makers, health plans and drug supply-chain middlemen have been blaming one another for rising drug prices, and FTC officials held the event to figure...